Skip to main content

Table 3 Comparison of subgroups by our definitions between GBS patients with and without elevated CK levels

From: Clinical features of Guillain–Barré syndrome patients with elevated serum creatine kinase levels

 GBS patients with elevated CK levels
(n = 14)
GBS patients with normal CK levels
(n = 37)
AIDP0 (0)15 (41)0.005
AMAN14 (100)22 (59)0.005
 AMAN with axonal degeneration3 (21)5 (14)NS
 AMAN with RCF11 (79)17 (46)NS
  1. Abbreviations: GBS Guillain–Barré syndrome, CK Creatine kinase, AIDP Acute inflammatory demyelinating polyneuropathy, AMAN Acute motor axonal neuropathy, RCF Reversible conduction failure, NS Not significant